Treatment of neonatal hemochromatosis with high-dose intravenous immunoglobulin during pregnancy
Not Applicable
- Conditions
- neonatal haemochromatosis
- Registration Number
- JPRN-UMIN000020469
- Lead Sponsor
- Department of Pediatrics, School of Medicine, Institute of Medical Pharmaceutical and Health Sciences, Kanazawa University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- Female
- Target Recruitment
- 2
Inclusion Criteria
Not provided
Exclusion Criteria
Women who had allergy for immunoglobulin.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method